Press News

Press News

Press News | 15.04.2026

Print:
Title Media Publ. Date
The new “gateway” to access innovative medicines Kathimerini 15/04/2026
Artificial intelligence and medicine: An unexpected return to the human being Ta Nea 15/04/2026
Behind-the-scenes conflicts over the elections and the Ministry’s intervention Ta Nea 15/04/2026

 

See here the publicity

 

Web Monitoring Report for the period 14/04 – 15/04

Title Media Publ. Date
Pharmaceutical companies: How up to €150 million will be offset for medicine research and development capital.gr 15/04/2026
New structure in the HTA Committee: Flora Bakopoulou reappointed as president healthpharma.gr 14/04/2026
EOPYY: How it will leverage Artificial Intelligence to audit doctors and healthcare providers – What the omnibus bill provides for healthreport.gr 15/04/2026
SFEE: The 2026–2027 investment clawback leaves innovation and patients out healthweb.gr 15/04/2026
SFEE: Three objections to the regulations on pharmaceutical investment clawback iatronet.gr 15/04/2026
The EU is investing 30 million euros to combat antimicrobial resistance iatronet.gr 15/04/2026
Investment clawback: SFEE calls for extending the measure to subsidiaries – The message to the government iatropedia.gr 15/04/2026
Fines and imports for medicine shortages – Production of innovative therapies in hospitals in.gr 15/04/2026
Leadership change at Pfizer Hellas – Vasilis Tzinieris is the new president news4health.gr 15/04/2026
“No” to the integration of EU4Health into a broader European Competitiveness Fund news4health.gr 14/04/2026
Production of innovative CAR-T therapies begins in the NHS – Through what process? ygeiamou.gr 15/04/2026

RELATED NEWS

Skip to content
SFEE
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.